Free Trial

Exelon Corporation $EXC Shares Sold by DRW Securities LLC

Exelon logo with Utilities background

Key Points

  • DRW Securities LLC significantly reduced its holdings in Exelon Corporation by 68.8%, owning 98,145 shares after selling 216,545 shares in the first quarter.
  • Exelon reported $0.39 earnings per share (EPS) for the latest quarter, exceeding expectations, with revenues totaling $5.43 billion, slightly below forecasts.
  • The company declared a quarterly dividend of $0.40, representing a 3.7% yield, with a dividend payout ratio of 60.84%.
  • MarketBeat previews top five stocks to own in October.

DRW Securities LLC lessened its holdings in Exelon Corporation (NASDAQ:EXC - Free Report) by 68.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 98,145 shares of the company's stock after selling 216,545 shares during the quarter. DRW Securities LLC's holdings in Exelon were worth $4,523,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Nuveen LLC purchased a new position in Exelon during the 1st quarter worth approximately $285,428,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Exelon by 43.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 12,846,030 shares of the company's stock valued at $483,525,000 after acquiring an additional 3,878,687 shares during the last quarter. GQG Partners LLC purchased a new stake in shares of Exelon in the 1st quarter valued at $112,832,000. Royal Bank of Canada boosted its holdings in shares of Exelon by 125.6% in the 4th quarter. Royal Bank of Canada now owns 3,838,729 shares of the company's stock valued at $144,489,000 after acquiring an additional 2,137,439 shares during the last quarter. Finally, T. Rowe Price Investment Management Inc. raised its position in Exelon by 13,334.4% during the first quarter. T. Rowe Price Investment Management Inc. now owns 2,038,539 shares of the company's stock valued at $93,936,000 after acquiring an additional 2,023,365 shares in the last quarter. Institutional investors and hedge funds own 80.92% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on EXC shares. Morgan Stanley reiterated an "outperform" rating on shares of Exelon in a research report on Thursday, August 21st. KeyCorp reduced their price target on Exelon from $39.00 to $37.00 and set an "underweight" rating for the company in a research report on Wednesday, July 16th. Finally, UBS Group restated a "neutral" rating and issued a $48.00 price objective (up from $47.00) on shares of Exelon in a research report on Friday, July 11th. Five analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $47.20.

Read Our Latest Analysis on EXC

Exelon Price Performance

Shares of EXC traded up $0.01 during trading hours on Wednesday, hitting $43.38. 7,903,245 shares of the stock were exchanged, compared to its average volume of 5,419,909. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.85 and a current ratio of 0.95. Exelon Corporation has a 12-month low of $35.94 and a 12-month high of $48.11. The company has a market cap of $43.81 billion, a price-to-earnings ratio of 16.42, a price-to-earnings-growth ratio of 2.56 and a beta of 0.41. The stock's 50-day moving average price is $43.95 and its two-hundred day moving average price is $44.20.

Exelon (NASDAQ:EXC - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported $0.39 EPS for the quarter, topping the consensus estimate of $0.37 by $0.02. Exelon had a return on equity of 9.85% and a net margin of 11.16%.The firm had revenue of $5.43 billion during the quarter, compared to analysts' expectations of $5.47 billion. During the same period in the previous year, the business earned $0.47 earnings per share. The firm's revenue for the quarter was up 1.2% on a year-over-year basis. Exelon has set its FY 2025 guidance at 2.640-2.740 EPS. Research analysts expect that Exelon Corporation will post 2.64 earnings per share for the current year.

Exelon Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Monday, August 11th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, August 11th. This represents a $1.60 dividend on an annualized basis and a yield of 3.7%. Exelon's payout ratio is 60.84%.

Exelon Company Profile

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Featured Stories

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.